Mendeleev Commun.,
2025 , том 35, выпуск 2, страницы 145–147
(Mi mendc1357)
Communications New thiosemicarbazones possessing activity against SARS-CoV-2 and H1N1 influenza viruses O. A. Zhupikova a ,
O. I. Yarovaya a ,
M. K. Marenina a ,
Yu. V. Meshkova a ,
S. V. Belenkaya ab ,
D. N. Shcherbakov ab ,
A. V. Zaykovskaya b ,
O. V. Pyankov b ,
V. V. Zarubaev c ,
M. G. Mikhalsky c ,
A. Yu. Fedorov d ,
S. G. Arkhipov d ,
V. I. Potkin e ,
I. A. Kolesnik e ,
A. V. Ivanov f ,
N. F. Salakhutdinov a ,
M. V. Khvostov a a N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russian Federation b State Research Center of Virology and Biotechnology ‘Vector’, 630559 Koltsovo, Novosibirsk Region, Russian Federation c St. Petersburg Pasteur Institute, 197101 St. Petersburg, Russian Federationy d Institute of Chemical Technology, Novosibirsk State University, 630090 Novosibirsk, Russian Federation e Institute of Physical Organic Chemistry, National Academy of Sciences of Belarus, 220072 Minsk, Belarus f A. E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch of the Russian Academy of Sciences, 664033 Irkutsk, Russian Federation Аннотация:
New thiosemicarbazones based on 5-arylisoxazole-3-carbaldehyde and substituted pyrrolecarbaldehydes have been obtained. The test for ability to inhibit the main viral protease 3Clpro of SARS-CoV-2 virus revealed a compound with activity against both corona- and influenza viruses.
Ключевые слова:
thiosemicarbazones, isoxazoles, tetrahydroindoles, antiviral activity, protease 3Clpro, SARS-CoV-2 virus, influenza A (H1N1) virus, biological activity.
Поступила в редакцию: 25.07.2024
Принята в печать: 03.10.2024
Язык публикации: английский
DOI:
10.71267/mencom.7578
© , 2025
Полный текст:
PDF файл (659 kB)
Первая страница:
PDF файл
